Intrinsic Value of S&P & Nasdaq Contact Us

Quantum BioPharma Ltd. QNTM NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
39/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — QNTM

Quantum BioPharma Ltd. (QNTM) has a market capitalization of $12.44M and trades at $3.02. The 52-week range is 2.07-38.25.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.4, Earnings Per Share (EPS) of $-8.11.

The stock has a beta of 0.32, operates in the Healthcare sector.

Trading Data
Current Price$3.02
52-Week Range2.07-38.25
Volume427.99K
Avg Volume (30D)312.95K
Market Cap$12.44M
Beta (1Y)0.32
Company
IPO Date2018-06-08
CEOLakshmi Kotra
CountryCA
ExchangeNASDAQ Global Market
CurrencyUSD
ISINCA74764Y2050
Income (Latest Year)
Gross Profit$-555.33K
EBITDA$-15.03M
Operating Income$-15.59M
Net Income$-26.63M
EPS$-8.11
EPS Diluted$-8.11
Shares Outstanding$3.29M
Balance Sheet (Latest Year)
Total Assets$11.14M
Current Assets$6.47M
Cash & ST Investments$6.17M
Total Liabilities$6.05M
Total Debt$1.87M
Net Debt$-29.09K
Total Equity$5.09M
Debt / Equity0.37
Valuation Ratios
P/E Ratio-0.4
P/B Ratio2.44
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message